Clinical trials – examining the patient experience

Clinical trials – examining the patient experience

Clinical research is essential in helping us find out if new therapies really do work and if they can make a difference to patients’ lives.

But with over 300,000 trials looking for around 44 million patients, conducting clinical research is becoming increasingly difficult. We know there are patients out there, often searching desperately for new options or alternatives that they haven’t already tried.

Havas Lynx Group launches white paper on Clinical Trials Day to address $40bn clinical trials challenge

Havas Lynx Group launches white paper on Clinical Trials Day to address $40bn clinical trials challenge

Patient centricity is a misused buzzword to signpost all manner of token efforts, but the real winners will be those who embrace it throughout their organisation. Not just because it’s the right thing to do, but because it is the only way to fix a broken model.

That is the clear message from Havas Lynx Group as it marks Clinical Trials Day (May 20th) with the launch of a new white paper designed to provoke conversation and offer potential solutions to a problem that is costing lives and the sector more than $40bn every year.